ReviewPharmacology & therapeutics2019
Targeting opioid dysregulation in depression for the development of novel therapeutics.
Caroline A Browne et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this papertrialcites it